Background: In April 2009, a novel influenza A (H1N1) pdm virus was identified in Mexico, and spread quickly around the world. We treated 5 patients with influenza-associated encephalopathy due to this virus. We investigated the clinical characteristics, treatments and outcomes. Methods: We studied patients with influenza-associated encephalopathy due to influenza A (H1N1) pdm that presented at the department of pediatrics at Nihon University Itabashi hospital between September 2009 and February 2010. Result: The 5 patients (1 boy, 4 girls), ranged in age from 6 years to 11 years, with an average age of 7 years and 11 months. In all patients, brain CT showed diffuse cerebral edema, and electro-encephalogram revealed diffuse high voltage slow waves in all leads. They were all treated with oseltamivir, and methyl-prednisolone pulse therapy in accordance with the guidelines for influenza-associated encephalopathy in Japan. Three patients recovered without any sequelae; however, the remaining two had residual neurological sequelae. These two patients presented with severe disturbance of consciousne, and their central nervous system symptoms appeared within 12 hours after the onset of fever. One patient had periventricular leukomalasia and symptomatic epilepsy by perinatal brain hypoxia, and the other patient had one complex febrile and two febrile seizure. Conclusion: This study showed that patients with influenza-associated encephalopathy due to novel influenza A (H1N1) pdm infection were all older than the average age of patients with seasonal influenza. Underlying neurological disease or past history may be associated with poor prognosis. Thus, further detailed studies are required.
View full abstract